Edition:
United Kingdom

OptiNose Inc (OPTN.OQ)

OPTN.OQ on NASDAQ Stock Exchange Global Select Market

7.40USD
16 Jan 2019
Change (% chg)

-- (--)
Prev Close
$7.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
87,039
52-wk High
$30.00
52-wk Low
$5.66

Latest Key Developments (Source: Significant Developments)

OptiNose Inc - Entered Into A Manufacturing Services Agreement For Subassembly With Advance Mold & Manufacturing
Wednesday, 26 Dec 2018 

Dec 26 (Reuters) - OptiNose Inc ::OPTINOSE INC - ENTERED INTO A MANUFACTURING SERVICES AGREEMENT FOR SUBASSEMBLY WITH ADVANCE MOLD & MANUFACTURING.OPTINOSE - INITIAL TERM OF AGREEMENT EXPIRES ON OCTOBER 24, 2021, BUT WILL AUTOMATICALLY RENEW FOR SUCCESSIVE ONE-YEAR TERMS.OPTINOSE INC - FLEX WILL MANUFACTURE LIQUID DELIVERY SUB-ASSEMBLY COMPONENT OF XHANCE.OPTINOSE INC - COMPANY IS REQUIRED TO PROVIDE ROLLING MONTHLY FORECASTS TO FLEX, OF WHICH A CERTAIN PORTION OF SUCH FORECASTS ARE BINDING.  Full Article

Optinose Qtrly Loss Per Share $0.61
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - OptiNose Inc ::OPTINOSE REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS.Q3 REVENUE $1.9 MILLION VERSUS I/B/E/S VIEW $1.8 MILLION.QTRLY LOSS PER SHARE $0.61.Q3 REVENUE VIEW $1.8 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

OptiNose Q2 Loss Per Share $0.64
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - OptiNose Inc ::OPTINOSE REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS.Q2 REVENUE $1.3 MILLION VERSUS I/B/E/S VIEW $1.2 MILLION.EXPECTS TO INITIATE A CLINICAL PROGRAM IN PURSUIT OF AN ADDITIONAL INDICATION FOR XHANCE FOR "TREATMENT OF CHRONIC SINUSITIS" IN Q4.BELIEVES THAT TOTAL GAAP OPERATING EXPENSES FOR 2018 WILL BE IN RANGE OF $117 MILLION - $121 MILLION.QTRLY LOSS PER SHARE $0.64.SAYS COMPANY HAD CASH AND CASH EQUIVALENTS OF $245.0 MILLION AS OF JUNE 30, 2018.  Full Article

OptiNose Files For Offering Of Common Stock - SEC Filing
Monday, 4 Jun 2018 

June 4 (Reuters) - OptiNose Inc ::OPTINOSE INC FILES FOR OFFERING OF COMMON STOCK - SEC FILING.OPTINOSE INC SAYS CO OFFERING 2.25 MILLION SHARES OF COMMON STOCK AND SELLING STOCKHOLDERS ARE OFFERING 2.25 MILLION SHARES OF COMMON STOCK.  Full Article

OptiNose Inc Qtrly Net Loss ‍$4.23 Per Share​
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Optinose Inc ::OPTINOSE INC - QTRLY NET LOSS ‍$4.23 PER SHARE​.  Full Article

Optinose Inc shares open at $20.00 in debut on the NASDAQ, up 25 pct versus IPO price
Friday, 13 Oct 2017 

Oct 13 (Reuters) - :Optinose Inc shares open at $20.00 in debut on the NASDAQ versus IPO price of $16.00 per share.  Full Article

Optinose prices initial public offering of 7.5 mln shares at $16/share
Friday, 13 Oct 2017 

Oct 12 (Reuters) - Optinose Inc IPO-OPNO.O:Optinose announces pricing of initial public offering.Says initial public offering of 7.50 million common shares priced at $16.00 per share.  Full Article